Skip to content

a16z Capital Management, L.L.C.

Follow

13F filer, CIK 1540358, MENLO PARK, CA

a16z Capital Management, L.L.C. reported $1,394,890,890 across 11 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14. Its ten largest share positions make up 99.89% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001540358-25-000007

Period
2025-09-30
Reported value
$1.39B
Holdings
11
Top 10 weight
99.89%
New
2
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
FIGnew+16,246,129$843M
METAnew+212,531$156M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
OPENexited-6,200,821-$3.31M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001540358-25-000007, largest first. % of portfolio is the value over $1,394,890,890, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 16,246,129 shares 16,246,129$843M60.41%newTimeline
METAMETA PLATFORMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 212,531 shares 212,531$156M11.19%newTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,748,523 shares; 2024Q4: 2,748,523 shares; 2025Q1: 2,748,523 shares; 2025Q2: 2,748,523 shares; 2025Q3: 2,748,523 shares 2,748,523$128M9.2%0Timeline
OMDAOMADA HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 4,614,574 shares; 2025Q3: 4,614,574 shares 4,614,574$102M7.31%0Timeline
XYZBLOCK INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,016,697 shares; 2024Q4: 1,016,697 shares; 2025Q1: 1,016,697 shares; 2025Q2: 1,016,697 shares; 2025Q3: 1,016,697 shares 1,016,697$73.5M5.27%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,702,225 shares; 2025Q2: 1,702,225 shares; 2025Q3: 1,702,225 shares 1,702,225$44.1M3.16%0Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,013,975 shares; 2024Q4: 3,233,170 shares; 2025Q1: 3,233,170 shares; 2025Q2: 3,233,170 shares; 2025Q3: 3,233,170 shares 3,233,170$19M1.36%0Timeline
NAUTNAUTILUS BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 17,653,917 shares; 2024Q4: 17,653,917 shares; 2025Q1: 17,653,917 shares; 2025Q2: 17,653,917 shares; 2025Q3: 17,653,917 shares 17,653,917$14.9M1.07%0Timeline
CAMPCAMP4 THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 2,125,339 shares; 2025Q1: 2,125,339 shares; 2025Q2: 2,125,339 shares; 2025Q3: 2,125,339 shares 2,125,339$6.38M0.46%0Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,862,500 shares; 2024Q4: 2,862,500 shares; 2025Q1: 2,862,500 shares; 2025Q2: 2,862,500 shares; 2025Q3: 2,862,500 shares 2,862,500$6.24M0.45%0Timeline
DNAGINKGO BIOWORKS HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 108,568 shares; 2024Q4: 108,568 shares; 2025Q1: 108,568 shares; 2025Q2: 108,568 shares; 2025Q3: 108,568 shares 108,568$1.58M0.11%0Timeline

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
OPENOPENDOOR TECHNOLOGIES INC6,200,821$3.31Mshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001540358-25-000007 base2025-11-14acceptance time not in the bulk data set